203 related articles for article (PubMed ID: 16971523)
1. Novel agonist monoclonal antibodies activate TrkB receptors and demonstrate potent neurotrophic activities.
Qian MD; Zhang J; Tan XY; Wood A; Gill D; Cho S
J Neurosci; 2006 Sep; 26(37):9394-403. PubMed ID: 16971523
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of six trkB antibodies reveals a novel class of functional agents for the study of the BDNF receptor.
Cazorla M; Arrang JM; Prémont J
Br J Pharmacol; 2011 Feb; 162(4):947-60. PubMed ID: 21039416
[TBL] [Abstract][Full Text] [Related]
3. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways.
Tsai T; Klausmeyer A; Conrad R; Gottschling C; Leo M; Faissner A; Wiese S
Mol Cell Neurosci; 2013 Sep; 56():18-28. PubMed ID: 23500004
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic effect of a novel TrkB agonist on retinal ganglion cells.
Hu Y; Cho S; Goldberg JL
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1747-54. PubMed ID: 19875669
[TBL] [Abstract][Full Text] [Related]
5. A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone.
Jang SW; Liu X; Yepes M; Shepherd KR; Miller GW; Liu Y; Wilson WD; Xiao G; Blanchi B; Sun YE; Ye K
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2687-92. PubMed ID: 20133810
[TBL] [Abstract][Full Text] [Related]
6. A small molecule TrkB/TrkC neurotrophin receptor co-activator with distinctive effects on neuronal survival and process outgrowth.
Yang T; Massa SM; Tran KC; Simmons DA; Rajadas J; Zeng AY; Jang T; Carsanaro S; Longo FM
Neuropharmacology; 2016 Nov; 110(Pt A):343-361. PubMed ID: 27334657
[TBL] [Abstract][Full Text] [Related]
7. Truncated trkB receptors on nonneuronal cells inhibit BDNF-induced neurite outgrowth in vitro.
Fryer RH; Kaplan DR; Kromer LF
Exp Neurol; 1997 Dec; 148(2):616-27. PubMed ID: 9417837
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical Characterization of Tropomyosin Receptor Kinase B-Agonistic Antibodies on Human Induced Pluripotent Stem (hiPS) Cell-Derived Neurons.
Traub S; Stahl H; Rosenbrock H; Simon E; Florin L; Hospach L; Hörer S; Heilker R
J Pharmacol Exp Ther; 2017 Jun; 361(3):355-365. PubMed ID: 28351853
[TBL] [Abstract][Full Text] [Related]
9. TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration.
Guo W; Pang K; Chen Y; Wang S; Li H; Xu Y; Han F; Yao H; Liu H; Lopes-Rodrigues V; Sun D; Shao J; Shen J; Dou Y; Zhang W; You H; Wu W; Lu B
Neurobiol Dis; 2019 Dec; 132():104590. PubMed ID: 31470106
[TBL] [Abstract][Full Text] [Related]
10. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
[TBL] [Abstract][Full Text] [Related]
11. Kalirin is required for BDNF-TrkB stimulated neurite outgrowth and branching.
Yan Y; Eipper BA; Mains RE
Neuropharmacology; 2016 Aug; 107():227-238. PubMed ID: 27036892
[TBL] [Abstract][Full Text] [Related]
12. Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents.
Massa SM; Yang T; Xie Y; Shi J; Bilgen M; Joyce JN; Nehama D; Rajadas J; Longo FM
J Clin Invest; 2010 May; 120(5):1774-85. PubMed ID: 20407211
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.
Todd D; Gowers I; Dowler SJ; Wall MD; McAllister G; Fischer DF; Dijkstra S; Fratantoni SA; van de Bospoort R; Veenman-Koepke J; Flynn G; Arjomand J; Dominguez C; Munoz-Sanjuan I; Wityak J; Bard JA
PLoS One; 2014; 9(2):e87923. PubMed ID: 24503862
[TBL] [Abstract][Full Text] [Related]
14. TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Wong AW; Giuffrida L; Wood R; Peckham H; Gonsalvez D; Murray SS; Hughes RA; Xiao J
Mol Cell Neurosci; 2014 Nov; 63():132-40. PubMed ID: 25461619
[TBL] [Abstract][Full Text] [Related]
15. A loss-of-function screen for phosphatases that regulate neurite outgrowth identifies PTPN12 as a negative regulator of TrkB tyrosine phosphorylation.
Ambjørn M; Dubreuil V; Miozzo F; Nigon F; Møller B; Issazadeh-Navikas S; Berg J; Lees M; Sap J
PLoS One; 2013; 8(6):e65371. PubMed ID: 23785422
[TBL] [Abstract][Full Text] [Related]
16. Tissue-Specificity of Antibodies Raised Against TrkB and p75
Fleury S; Boukhatem I; Le Blanc J; Welman M; Lordkipanidzé M
Front Immunol; 2021; 12():606861. PubMed ID: 33643311
[TBL] [Abstract][Full Text] [Related]
17. Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons.
Dedoni S; Olianas MC; Ingianni A; Onali P
J Neurochem; 2012 Jul; 122(1):58-71. PubMed ID: 22533963
[TBL] [Abstract][Full Text] [Related]
18. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex.
Sometani A; Kataoka H; Nitta A; Fukumitsu H; Nomoto H; Furukawa S
J Neurosci Res; 2001 Nov; 66(3):369-76. PubMed ID: 11746354
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular Nanostructure Activates TrkB Receptor Signaling of Neuronal Cells by Mimicking Brain-Derived Neurotrophic Factor.
Edelbrock AN; Àlvarez Z; Simkin D; Fyrner T; Chin SM; Sato K; Kiskinis E; Stupp SI
Nano Lett; 2018 Oct; 18(10):6237-6247. PubMed ID: 30211565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
